This inventor holds 1 USPTO granted patent. Top assignee: Ferring B.v.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Nicholas John Arrowsmith: Pharmaceutical Formulation Inventor
Introduction
Nicholas John Arrowsmith is an inventor associated with Nottingham, Great Britain. His patent work concerns pharmaceutical formulations designed to deliver active substances within biodegradable polymer matrices.
Latest Patents
The supplied information lists one patent for Arrowsmith: “Microparticles comprising GNRH made by PGSS.” It describes a pharmaceutical formulation containing a solid matrix of one or more biodegradable polymers, with a pharmaceutically active substance or an acceptable salt distributed homogeneously or substantially homogeneously throughout the matrix. Examples of the active substance include gonadotropin-releasing hormone (GnRH), a GnRH agonist, or a GnRH antagonist. The formulation is associated with Ferring B.V.
Career Highlights
Arrowsmith’s listed patent reflects work on microparticle-based drug formulations and the use of biodegradable polymers to incorporate pharmaceutical compounds. The supplied data identifies 1 patent associated with him.
Collaborations
The supplied information names Mark Andrew Whitaker and Gregoire Charles Joseph Schwach as Arrowsmith’s coworkers.
Conclusion
Nicholas John Arrowsmith’s recorded invention focuses on incorporating GnRH-related substances into biodegradable polymer microparticles, highlighting a pharmaceutical formulation approach associated with Ferring B.V.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
